Skip to main content
lexblog.com/lib/9FGJK5RJviewrecordjson
LEX-WK-9FGJK5RJcrawled 2025-03-21 08:59Z

FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies

Amanda Bogle · Kendall Kohlmeyer · Carly Eisenberg Hoinacki · Healthcare Law Blog · Published March 21, 2025

Work details

published
2025-03-21

Citation

Amanda Bogle, Kendall Kohlmeyer, Carly Eisenberg Hoinacki, FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies, Healthcare Law Blog (March 21, 2025) [The Library at LexBlog, LEX-WK-9FGJK5RJ, lexpid.org/9FGJK5RJ]